Drug Catalog - Product Detail
HYDROCORTISONE ACETATE/PRAMOXINE HCL CREAM (PRAMCORT) CRM 1%/1% 30GM
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 49908-0150-30 | ROCHESTER PHARMACEUTICALS | 30 | 1-1% | CREAM |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION PramCort Cream 1% is a topical preparation containing hydrocortisone acetate 1% w/w and pramoxine hydrochloride 1% w/w in a cream base containing: ceresin wax, cetyl alcohol, isopropyl palmitate, lanolin alcohol, mineral oil, panthenol, polyoxyl 40 stearate, potassium sorbate, propylene glycol, purified water, sorbic acid, stearic acid, triethanolamine lauryl sulfate, and white petrolatum. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. chemical structure: chemical structure
How Supplied
HOW SUPPLIED PramCort Cream 1% is supplied in 1 oz. tubes, NDC 49908-150-30. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Storage Conditions: Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted between 15ºC and 30ºC (between 59ºF and 86ºF). Brief exposure to temperatures up to 40ºC (104ºF) may be tolerated provided the mean kinetic temperature does not exceed 25ºC (77ºF); however, such exposure should be minimized. Protect from freezing. Manufactured for: Rochester Pharmaceuticals Doylestown, PA 18901 1-866-458-1772 www.RochesterPharm.com PRM-PI-0915
Indications & Usage
INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and Administration
DOSAGE & ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.